A compound, which is 1-(1,3-bis(methylthio)propoxy)-3-(methylthio)propan-1-ol, a composition containing the compound, a method for the preparation thereof, a method for preparing 3-methylthiopropionaldehyde by reacting 1-(1,3-bis(methylthio)propoxy)-3-(methylthio)propan-1-ol with acrolein, and also to the use of 1-(1,3-bis(methylthio)propoxy)-3-(methylthio)propan-1-ol or compositions containing the compound for the storage and/or transport of 3-methylthiopropionaldehyde and/or methyl mercaptan.

A compound, which is 1-(1,3-bis(methylthio)propoxy)-3-(methylthio)propan-1-ol, a composition containing the compound, a method for the preparation thereof, a method for preparing 3-methylthiopropionaldehyde by reacting 1-(1,3-bis(methylthio)propoxy)-3-(methylthio)propan-1-ol with acrolein, and also to the use of 1-(1,3-bis(methylthio)propoxy)-3-(methylthio)propan-1-ol or compositions containing the compound for the storage and/or transport of 3-methylthiopropionaldehyde and/or methyl mercaptan.

A method of producing an organopolysulfide or salt thereof is provided which includes a step of mixing an organomonosulfide or salt thereof and elemental sulfur, wherein the mixing is carried out at a temperature not greater than 95 C and in the absence of any added liquid phase for a time effective to produce the organopolysulfide or salt thereof. The described method makes possible the preparation of organopolysulfides and organopolysulfide salts without the use of solvent or catalyst.

A method of producing an organopolysulfide or salt thereof is provided which includes a step of mixing an organomonosulfide or salt thereof and elemental sulfur, wherein the mixing is carried out at a temperature not greater than 95 C and in the absence of any added liquid phase for a time effective to produce the organopolysulfide or salt thereof. The described method makes possible the preparation of organopolysulfides and organopolysulfide salts without the use of solvent or catalyst.

Compounds which directly inhibit IRE-1 activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.

A process for the preparation of methionine ?-hydroxy analogue and derivatives thereof comprising contacting one or more sugars or derivatives thereof with a metallo-silicate composition in the presence of a compound comprising sulphur and a solvent.

A process for the preparation of methionine ?-hydroxy analogue and derivatives thereof comprising contacting one or more sugars or derivatives thereof with a metallo-silicate composition in the presence of a compound comprising sulphur and a solvent.

The present invention relates to a Sonogashira-Carbonylation reaction using two types of gas, as well as novel crystals which can control a heat of the said reaction and the process of producing the same. In addition, the present invention relates to a ligand (additive) to prevent the deactivation of a palladium catalyst.

The present invention relates to a Sonogashira-Carbonylation reaction using two types of gas, as well as novel crystals which can control a heat of the said reaction and the process of producing the same. In addition, the present invention relates to a ligand (additive) to prevent the deactivation of a palladium catalyst.

A chain transfer agent composition comprises at least one branched C.sub.10 mercaptan selected from 5-methyl-1-mercapto-nonane, 3-propyl-1-mercapto-heptane, 4-ethyl-1-mercapto-octane, 2-butyl-1-mercapto-hexane, 5-methyl-2-mercapto-nonane, 3-propyl-2-mercapto-heptane, 4-ethyl-2-mercapto-octane, 5-methyl-5-mercapto-nonane, or combinations thereof. The chain transfer agent composition can be a component of an emulsion polymerization mixture and can be used in a process for emulsion polymerization for the production of polymers, for example, via free-radical polymerization.